Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19

NCT05268939 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

668

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Influenza A
Influenza Type B
RSV Infection

Interventions

DIAGNOSTIC_TEST: LumiraDx SARS-CoV-2 & Flu A/B test
DIAGNOSTIC_TEST: LumiraDx SARS-CoV-2 & RSV test

Sponsor

LumiraDx UK Limited